Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 4/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL280570 | 0.97 | KIF11 (0.42) | NPY5RKIF11RAB9AKDM4EMAPT | |
| SCHEMBL263043 | 0.90 | NPC1 (0.42) | KIF11RAB9AKDM4EMAPTALDH1A1 | |
| SCHEMBL280541 | 0.90 | KIF11 (0.47) | KIF11RAB9AKDM4EMAPTATM | |
| SCHEMBL14092199 | 0.89 | NPY5R (0.33) | NPY5RKIF11RAB9ATSHRPTGER4 | |
| SCHEMBL13330454 | 0.89 | ALDH1A1 (0.37) | NPY5RKIF11PTGER4KDM4EMAPT | |
| SCHEMBL11921142 | 0.86 | NPY5R (0.31) | NPY5R | |
| SCHEMBL21037653 | 0.85 | TSPO (0.45) | NPY5RRAB9ATSHRKDM4EATM | |
| SCHEMBL263047 | 0.84 | PTGER4 (0.38) | NPY5RKIF11RAB9APTGER4KDM4E | |
| SCHEMBL15435756 | 0.84 | L3MBTL1 (0.46) | NPY5RRAB9ATSHRPTGER4KDM4E | |
| SCHEMBL263064 | 0.84 | NPY5R (0.40) | NPY5RKIF11RAB9APTGER4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8816098-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using the anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-08-26 | — | — | US | disclosed |
| US-8530672-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-09-10 | — | — | US | disclosed |
| US-20120309984-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-12-06 | — | — | US | disclosed |
| US-8278655-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-02 | — | — | US | disclosed |
| US-20120104379-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-03 | — | — | US | disclosed |
| US-8134147-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-03-13 | — | — | US | disclosed |
| US-8134147-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-03-13 | — | — | US | disclosed |
| US-20100200847-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-08-12 | — | — | US | disclosed |
| US-20100200847-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-08-12 | — | — | US | disclosed |
| US-7723722-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-05-25 | — | — | US | disclosed |
| US-7723722-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120104379-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | CYP1A1, XPO7, AMY1A | NPY5R 4134/4885KIF11 4217/4885RAB9A 3988/4885 |
| US-20120309984-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | CYP1A1, XPO7, AMY1A | NPY5R 4134/4885KIF11 4217/4885RAB9A 3988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.